Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/EBITDA ratio high or low?
The EV/EBITDA ratio of 4.30x is 75% below its estimated 5-year average of 17.47x, near the low end of its estimated 5-year range (2.52x–197.72x).
As of 2026-10-06T19:07:36.681Z. 15.77% above its estimated 12-month average of 3.71x.
Calculation as of: 2026-10-06T19:07:36.681Z.
Quote observation: 2026-10-06T19:05:20.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 49956d752354928fb07628098103860bf0417df2cd3b389d25b323b6b5b3ce2a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
4.30x
EV/EBITDA RATIO AVG TTM
3.71x
EV/EBITDA RATIO AVG 3Y
17.44x
EV/EBITDA RATIO AVG 5Y
17.47x
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+15.77%
CURRENT VS 3Y AVG
-75.35%
CURRENT VS 5Y AVG
-75.39%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
15.76x
median of 217 covered companies
CURRENT VS SECTOR MEDIAN
-72.72%
vs the sector median at left
Nutex Health, Inc.
Market Cap
$1.52B
EV/EBITDA Ratio
4.30x
TTM Avg
3.71x
3Y Avg
17.44x
5Y Avg
17.47x
Market Cap
$1.54B
EV/EBITDA Ratio
N/A
TTM Avg
399.33x
3Y Avg
399.33x
5Y Avg
399.33x
Market Cap
$1.50B
EV/EBITDA Ratio
72.08x
TTM Avg
329.18x
3Y Avg
230.60x
5Y Avg
237.22x
Market Cap
$1.48B
EV/EBITDA Ratio
8.84x
TTM Avg
11.44x
3Y Avg
12.12x
5Y Avg
11.37x
Market Cap
$1.47B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.57B
EV/EBITDA Ratio
N/A
TTM Avg
37.36x
3Y Avg
37.36x
5Y Avg
37.36x
Market Cap
$1.46B
EV/EBITDA Ratio
N/A
TTM Avg
5.67x
3Y Avg
5.67x
5Y Avg
5.67x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nutex Health, Inc. (NUTX) | $1.52B | 4.30x | 3.71x | 17.44x | 17.47x |
| Innoviva, Inc. (INVA)vs › | $1.54B | 4.92x | 69.99x | 32.98x | 22.10x |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | N/A | 399.33x | 399.33x | 399.33x |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.50B | 72.08x | 329.18x | 230.60x | 237.22x |
| Phibro Animal Health Corporation (PAHC)vs › | $1.48B | 8.84x | 11.44x | 12.12x | 11.37x |
| Rapport Therapeutics, Inc. Common Stock (RAPP)vs › | $1.47B | N/A | N/A | N/A | N/A |
| GH Research PLC (GHRS)vs › | $1.47B | N/A | N/A | N/A | N/A |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.57B | N/A | 37.36x | 37.36x | 37.36x |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.46B | N/A | 5.67x | 5.67x | 5.67x |
| Certara, Inc. (CERT)vs › | $1.45B | 26.44x | 16.63x | 66.61x | 73.09x |
At 4.3, EV/EBITDA is below its estimated 8-year median — higher than 31% of readings in its estimated 8-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 8-year low
2.5
median
13.7
estimated 8-year high
11976.4
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-10-05 | 4.47x |
| 2026-10-02 | 4.31x |
| 2026-10-01 | 4.24x |
| 2026-09-30 | 4.23x |
| 2026-09-29 | 4.20x |
| 2026-09-28 | 4.25x |
| 2026-09-25 | 4.38x |
| 2026-09-24 | 4.10x |
| 2026-09-23 | 4.05x |
| 2026-09-22 | 4.17x |
| 2026-09-21 | 4.04x |
| 2026-09-18 | 4.17x |
| 2026-09-17 | 4.27x |
| 2026-09-16 | 4.33x |
| 2026-09-15 | 4.29x |
| 2026-09-14 | 4.32x |
| 2026-09-11 | 4.02x |
| 2026-09-10 | 3.93x |
| 2026-09-09 | 3.97x |
| 2026-09-08 | 3.84x |
| 2026-09-04 | 3.89x |
| 2026-09-03 | 3.97x |
| 2026-09-02 | 3.87x |
| 2026-09-01 | 3.78x |
| 2026-08-31 | 3.81x |
| 2026-08-28 | 3.82x |
| 2026-08-27 | 3.90x |
| 2026-08-26 | 3.94x |
| 2026-08-25 | 3.80x |
| 2026-08-24 | 3.79x |
| 2026-08-21 | 3.76x |
| 2026-08-20 | 3.80x |
| 2026-08-19 | 3.84x |
| 2026-08-18 | 3.79x |
| 2026-08-17 | 3.80x |
| 2026-08-14 | 3.78x |
| 2026-08-13 | 3.77x |
| 2026-08-12 | 3.51x |
| 2026-08-11 | 3.40x |
| 2026-08-10 | 3.97x |
| 2026-08-07 | 3.32x |
| 2026-08-06 | 4.15x |
| 2026-08-05 | 4.28x |
| 2026-08-04 | 4.29x |
| 2026-08-03 | 4.17x |
| 2026-07-31 | 4.04x |
| 2026-07-30 | 4.07x |
| 2026-07-29 | 3.87x |
| 2026-07-28 | 4.08x |
| 2026-07-27 | 4.07x |
| 2026-07-24 | 4.00x |
| 2026-07-23 | 4.19x |
| 2026-07-22 | 4.27x |
| 2026-07-21 | 4.54x |
| 2026-07-20 | 4.38x |
| 2026-07-17 | 4.41x |
| 2026-07-16 | 4.45x |
| 2026-07-15 | 4.73x |
| 2026-07-14 | 4.79x |
| 2026-07-13 | 4.80x |
| 2026-07-10 | 4.92x |
| 2026-07-09 | 4.91x |
| 2026-07-08 | 4.81x |
| 2026-07-07 | 5.02x |
| 2026-07-06 | 5.15x |
| 2026-07-02 | 5.22x |
| 2026-07-01 | 5.08x |
| 2026-06-30 | 4.60x |
| 2026-06-29 | 4.53x |
| 2026-06-26 | 4.50x |
| 2026-06-25 | 4.08x |
| 2026-06-24 | 4.04x |
| 2026-06-23 | 4.03x |
| 2026-06-22 | 4.10x |
| 2026-06-18 | 4.11x |
| 2026-06-17 | 4.01x |
| 2026-06-16 | 3.96x |
| 2026-06-15 | 4.03x |
| 2026-06-12 | 3.96x |
| 2026-06-11 | 4.03x |
| 2026-06-10 | 3.70x |
| 2026-06-09 | 3.75x |
| 2026-06-08 | 3.72x |
| 2026-06-05 | 3.68x |
| 2026-06-04 | 3.74x |
| 2026-06-03 | 3.69x |
| 2026-06-02 | 3.50x |
| 2026-06-01 | 3.57x |
| 2026-05-29 | 3.60x |
| 2026-05-28 | 3.63x |
| 2026-05-27 | 3.36x |
| 2026-05-26 | 3.45x |
| 2026-05-22 | 3.35x |
| 2026-05-21 | 3.35x |
| 2026-05-20 | 3.41x |
| 2026-05-19 | 3.53x |
| 2026-05-18 | 3.49x |
| 2026-05-15 | 3.53x |
| 2026-05-14 | 3.56x |
| 2026-05-13 | 3.66x |
| 2026-05-12 | 3.75x |
| 2026-05-11 | 3.69x |
| 2026-05-08 | 3.78x |
| 2026-05-07 | 3.73x |
| 2026-05-06 | 3.63x |
| 2026-05-05 | 3.40x |
| 2026-05-04 | 4.03x |
| 2026-05-01 | 3.85x |
| 2026-04-30 | 3.55x |
| 2026-04-29 | 3.37x |
| 2026-04-28 | 3.45x |
| 2026-04-27 | 3.34x |
| 2026-04-24 | 3.28x |
| 2026-04-23 | 3.30x |
| 2026-04-22 | 3.28x |
| 2026-04-21 | 3.23x |
| 2026-04-20 | 3.30x |
| 2026-04-17 | 3.21x |
| 2026-04-16 | 3.12x |
| 2026-04-15 | 3.30x |
| 2026-04-14 | 3.27x |
| 2026-04-13 | 3.23x |
| 2026-04-10 | 3.10x |
| 2026-04-09 | 3.21x |
| 2026-04-08 | 3.20x |
| 2026-04-07 | 3.14x |
| 2026-04-06 | 3.09x |
| 2026-04-02 | 3.09x |
| 2026-04-01 | 3.03x |
| 2026-03-31 | 2.95x |
| 2026-03-30 | 2.84x |
| 2026-03-27 | 2.92x |
| 2026-03-26 | 2.94x |
| 2026-03-25 | 3.08x |
| 2026-03-24 | 3.06x |
| 2026-03-23 | 2.95x |
| 2026-03-20 | 2.80x |
| 2026-03-19 | 2.94x |
| 2026-03-18 | 2.92x |
| 2026-03-17 | 2.92x |
| 2026-03-16 | 2.89x |
| 2026-03-13 | 2.79x |
| 2026-03-12 | 2.75x |
| 2026-03-11 | 2.83x |
| 2026-03-10 | 2.99x |
| 2026-03-09 | 3.04x |
| 2026-03-06 | 2.83x |
| 2026-03-05 | 2.64x |
| 2026-03-04 | 2.70x |
| 2026-03-03 | 2.77x |
| 2026-03-02 | 2.88x |
| 2026-02-27 | 2.74x |
| 2026-02-26 | 2.84x |
| 2026-02-25 | 2.70x |
| 2026-02-24 | 2.52x |
| 2026-02-23 | 2.57x |
| 2026-02-20 | 2.56x |
| 2026-02-19 | 2.60x |
| 2026-02-18 | 2.62x |
| 2026-02-17 | 2.56x |
| 2026-02-13 | 2.53x |
| 2026-02-12 | 2.63x |
| 2026-02-11 | 2.59x |
| 2026-02-10 | 2.56x |
| 2026-02-09 | 2.62x |
| 2026-02-06 | 2.53x |
| 2026-02-05 | 2.57x |
| 2026-02-04 | 3.02x |
| 2026-02-03 | 3.59x |
| 2026-02-02 | 3.72x |
| 2026-01-30 | 3.48x |
| 2026-01-29 | 3.47x |
| 2026-01-28 | 3.50x |
| 2026-01-27 | 3.58x |
| 2026-01-26 | 3.69x |
| 2026-01-23 | 3.62x |
| 2026-01-22 | 3.68x |
| 2026-01-21 | 3.44x |
| 2026-01-20 | 3.57x |
| 2026-01-16 | 3.56x |
| 2026-01-15 | 3.78x |
| 2026-01-14 | 3.81x |
| 2026-01-13 | 3.94x |
| 2026-01-12 | 4.10x |
| 2026-01-09 | 4.20x |
| 2026-01-08 | 4.16x |
| 2026-01-07 | 4.05x |
| 2026-01-06 | 3.93x |
| 2026-01-05 | 3.84x |
| 2026-01-02 | 3.47x |
| 2025-12-31 | 3.78x |
| 2025-12-30 | 4.13x |
| 2025-12-29 | 4.16x |
| 2025-12-26 | 4.02x |
| 2025-12-24 | 3.85x |
| 2025-12-23 | 3.84x |
| 2025-12-22 | 4.07x |
| 2025-12-19 | 3.93x |
| 2025-12-18 | 3.83x |
| 2025-12-17 | 3.68x |
| 2025-12-16 | 3.92x |
| 2025-12-15 | 4.00x |
| 2025-12-12 | 4.18x |
| 2025-12-11 | 4.29x |
| 2025-12-10 | 4.01x |
| 2025-12-09 | 3.86x |
| 2025-12-08 | 4.10x |
| 2025-12-05 | 3.71x |
| 2025-12-04 | 3.63x |
| 2025-12-03 | 3.15x |
| 2025-12-02 | 3.11x |
| 2025-12-01 | 2.91x |
| 2025-11-28 | 2.83x |
| 2025-11-26 | 2.78x |
| 2025-11-25 | 2.91x |
| 2025-11-24 | 3.25x |
| 2025-11-21 | 3.25x |
| 2025-11-20 | 3.35x |
| 2025-11-19 | 3.62x |
| 2025-11-18 | 3.78x |
| 2025-11-17 | 3.91x |
| 2025-11-14 | 3.99x |
| 2025-11-13 | 4.04x |
| 2025-11-12 | 4.38x |
| 2025-11-11 | 4.12x |
| 2025-11-10 | 4.30x |
| 2025-11-07 | 4.19x |
| 2025-11-06 | 4.38x |
| 2025-11-05 | 4.63x |
| 2025-11-04 | 4.51x |
| 2025-11-03 | 4.64x |
| 2025-10-31 | 4.42x |
| 2025-10-30 | 4.45x |
| 2025-10-29 | 4.54x |
| 2025-10-28 | 4.56x |
| 2025-10-27 | 4.59x |
| 2025-10-24 | 4.48x |
| 2025-10-23 | 4.26x |
| 2025-10-22 | 4.18x |
| 2025-10-21 | 4.19x |
| 2025-10-20 | 4.10x |
| 2025-10-17 | 3.67x |
| 2025-10-16 | 3.72x |
| 2025-10-15 | 3.96x |
| 2025-10-14 | 3.79x |
| 2025-10-13 | 3.86x |
| 2025-10-10 | 3.67x |
| 2025-10-09 | 3.90x |
| 2025-10-08 | 3.88x |
| 2025-10-07 | 3.88x |
| 2025-10-06 | 4.03x |
| 2025-10-03 | 4.01x |
| 2025-10-02 | 4.00x |
| 2025-10-01 | 3.92x |
| 2025-09-30 | 3.89x |
| 2025-09-29 | 3.97x |
| 2025-09-26 | 3.87x |
| 2025-09-25 | 3.73x |
| 2025-09-24 | 3.81x |
| 2025-09-23 | 3.90x |
Showing the most recent 260 of 926 data points. The chart above shows the full history.
